Getting The Balance Right: Companies Juggle UK QPPV & National Contact Person Roles
Executive Summary
A senior MHRA inspector explains the nuanced differences between the newly created UK roles of qualified person for pharmacovigilance and national contact person to help companies position the two individuals appropriately within their organizational structures.
You may also be interested in...
UK Offers Pragmatic Approach To Safety Reporting From Jan 2021
The UK’s approach to pharmacovigilance system requirements in the post-Brexit transition period will allow companies to leverage some of the existing structures put in place for EU systems.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.